Missing/wrong data?
Edit Wikidata item
Faculty Opinions recommendation of LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ERα pathway.
Author/s
author: Wafik El-Deiry
Work details
Publication date
October 11, 2018
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.